42 items
2026-09-11
SEKISUI HEIM CO., LTD. announced that it has received ¥12,970 million in fudning from returning investor, Sekisui Chemical Co., Ltd. on Septemebr 10, 2026. The company issued convertible preferred shares in the transaction. After completion of the transaction, the capital increased upto ¥13,000 million. The transaction expected to be closed on October 1, 2026.
2026-09-10
Sekisui Chemical Co., Ltd., Board Meeting, Sep 10, 2026. Agenda: To consider acquisition of shares of ausbuild group to make it a subsidiary, a residential land development and housing construction company based in Queensland, Australia.
2026-08-01
Sekisui Chemical Co., Ltd. revised consolidated earnings guidance for the first half ending September 30, 2026. For the period the company expects net sales of JPY 690,500 million, operating profit of JPY 48,000 million, profit attributable to owners of parent of JPY 30,800 million, and net profit per share of JPY 76.28, compared to previous forecast for net sales of JPY 676,800 million, operating profit of JPY 46,400 million, and profit attributable to owners of parent of JPY 30,800 million, and net profit per share of JPY 76.29. Regarding the forecast of consolidated results for the first half of fiscal 2026, the prices of raw materials and parts surged, but this was offset through sales price improvements, and exchange rates have moved in the direction of a weaker yen. In light of these factors, the company revised the forecast announced on April 28, 2026.
2026-08-01
Sekisui Chemical Co., Ltd. provides consolidated earnings guidance for the full year ending March 31, 2027. For the period, the company expects net sales of JPY 1,408,400 million, operating profit of JPY 115,000 million, profit attributable to owners of parent of JPY 76,000 million, and profit attributable to owners of parent per share of JPY 188.21.
2026-07-27
Sekisui Chemical Co., Ltd. (TSE:4204) agreed to acquire NobleHome inc. and its five other related companies on June 22, 2026. For the period ending September 30, 2025, NobleHome inc. reported total revenue of ¥25.5 billion. The transaction is expected to be completed in the second half of fiscal year 2026.
2026-07-24
Sekisui Chemical Co., Ltd., ¥ 40.0, Cash Dividend, Sep-29-2026
2026-07-16
President's Small Meeting for Sell-side Analysts
2026-07-15
Sekisui Chemical Co., Ltd., Q1 2027 Earnings Call, Jul 31, 2026
2026-06-27
Sekisui Chemical Co., Ltd. announced that they will report Q1, 2027 results on Jul 31, 2026
2026-05-23
FY2026-2028 Medium-term Management Plan, Accelerate 2028
2026-05-18
Sekisui Chemical Co., Ltd., Board Meeting, May 18, 2026. Agenda: To pay out dividend of surplus with March 31, 2026.
2026-05-04
Sekisui Chemical Co., Ltd. proposed year end dividend for the fiscal year ended March 31, 2026. For the year end, the company proposed dividend of JPY 40 per share against JPY 42 per share a year ago. Scheduled date to commence dividend payments: June 22, 2026. Scheduled date of annual general meeting of shareholders: June 19, 2026.
2026-05-04
Sekisui Chemical Co., Ltd. provided year-end dividend guidance for fiscal year ending March 31, 2027. For the period, the company expects dividend of JPY 41.00 per share against JPY 40.00 per share paid a year ago.
2026-05-04
Sekisui Chemical Co., Ltd. provided consolidated earnings guidance for the first half and full year ending March 31, 2027. For the first half, the company expects net sales to be JPY 676,800 million, operating profit to be JPY 46,400 million, profit attributable to owners of parent to be JPY 30,800 million and profit attributable to owners of the parent per share to be JPY 76.29. For the full year, the company expects net sales to be JPY 1,408,400 million, operating profit to be JPY 115,000 million, profit attributable to owners of parent to be JPY 76,000 million and profit attributable to owners of the parent per share to be JPY 188.26.
2026-04-29
Sekisui Chemical Co., Ltd. expected to report Q1 2027 results on July 28, 2026. This event was calculated by S&P Global (Created on April 29, 2026).
2026-04-29
Sekisui Chemical Co., Ltd. reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 1,309,281 million compared to JPY 1,297,754 million a year ago. Net income was JPY 75,174 million compared to JPY 81,925 million a year ago. Basic earnings per share from continuing operations was JPY 182.7 compared to JPY 195.93 a year ago.
2026-04-28
Sekisui Chemical Co., Ltd. (TSE:4204) announces a share repurchase program. Under the program, the company will repurchase 4,000,000 shares, representing 0.99% of its share capital, for ¥12,000 million. The company will repurchase its shares as part of shareholder returns. The repurchased shares will be cancelled. The program will run until March 31, 2027. As of March 31, 2026, the company had 405,092,498 shares outstanding (excluding treasury shares) and 25,414,787 shares in treasury.
2026-04-28
The Board of Directors of Sekisui Chemical Co., Ltd. has authorized a buyback plan on April 28, 2026.
2026-04-28
Sekisui Chemical Co., Ltd., Annual General Meeting, Jun 19, 2026, at 10:00 Tokyo Standard Time. Location: THE BALLROOM 7th Floor THE OSAKA STATION HOTEL 2-2 Umeda 3-Chome, Kita-Ku, Osaka Japan Agenda: To consider report on the business report, the consolidated accounting documents, the non-consolidated accounting documents and the report on the results of the audits of consolidated accounting documents by the accounting auditor and the audit & supervisory board for the 104th business term (from April 1, 2025 to March 31, 2026); to consider appropriation of surplus; to consider election of nine directors; to consider election of one audit & supervisory board member.
2026-04-28
Sekisui Chemical Co., Ltd., Board Meeting, Apr 28, 2026. Agenda: To consider the purchase of treasury shares; and to consider the cancellation of treasury shares.
2026-04-16
Sekisui Chemical Co., Ltd., 2026 Earnings Call, Apr 28, 2026
2026-03-27
Sekisui Chemical Co., Ltd. announced that they will report fiscal year 2026 results at 3:30 PM, Tokyo Standard Time on Apr 28, 2026
2026-02-17
Sekisui Chemical Co., Ltd., Board Meeting, Feb 17, 2026. Agenda: To consider to make changes of Representative Directors.
2026-02-17
SEKISUI CHEMICAL CO., LTD. announced that it has decided at the meeting of its board of directors held on February 17, 2026 to make changes of Representative Directors. The company appointed Keita Kato as Chairman of the Board and Director from President and Representative Director of the company. Date of the changes: March 1, 2026.
2026-02-17
SEKISUI CHEMICAL CO., LTD. announced that it has decided at the meeting of its board of directors held on February 17, 2026 to make changes of Representative Directors. Ikusuke Shimizu appointed as President and Representative Director from Representative Director of the company. The company appointed Keita Kato as Chairman of the Board and Director from President and Representative Director of the company. Date of the changes: March 1, 2026. Ikusuke Shimizu was born on December 12, 1964. He joined SEKISUI CHEMICAL in April 1987. He was Executive Officer, High Performance Plastics Company, General Manager of Foam Business Division in April 2015. He became Managing Executive Officer, President of High Performance Plastics Company, Responsible for Electronic Business field in January 2019. He was Director, Managing Executive Officer, President of High Performance Plastics Company in June 2019. He was Director, Senior Managing Executive Officer, President of High Performance Plastics Company in April 2021. He was Representative Director Senior Managing Executive Officer, Responsible for ESG Management Department, New Business Development Department, Head of Business Strategy Department in January 2025. He was Representative Director Senior Managing Executive Officer, Responsible for ESG Management Department, Corporate Communication Department, New Business Development Department and Life Science Business Development Department, Head of Business Strategy Department in April 2025.
2026-02-09
From January 1, 2026 to February 9, 2026, the company has repurchased 3,758,000 shares, representing 0.92% for ¥10,443.46 million. With this, the company has completed the repurchase of 10,000,000 shares, representing 2.43% for ¥26,420.48 million under the buyback announced on October 30, 2025.
2026-02-09
The company closed its plan on February 9, 2026.
2026-01-31
Sekisui Chemical Co., Ltd. reported earnings results for the third quarter and nine months ended December 31, 2025. For the third quarter, the company reported sales was JPY 330,110 million compared to JPY 326,287 million a year ago. Net income was JPY 16,108 million compared to JPY 25,569 million a year ago. For the nine months, sales was JPY 959,907 million compared to JPY 955,342 million a year ago. Net income was JPY 47,831 million compared to JPY 68,495 million a year ago. Basic earnings per share from continuing operations was JPY 115.62 compared to JPY 163.73 a year ago.
2026-01-29
Sekisui Chemical Co., Ltd. revised earnings guidance for the year ended March 31, 2026. for the year, the company expects net sales of JPY 1,327,900 million, operating profit at JPY 110,000 million and profit attributable to owners of the parent at JPY 72,000 million, with earnings per share expected to be JPY 176.70 per share.
2026-01-22
Sekisui Chemical Co., Ltd., Q3 2026 Earnings Call, Jan 29, 2026
2026-01-14
Sekisui Chemical Co., Ltd., Board Meeting, Dec 16, 2025. Agenda: To consider overview of dividend; to consider financial impact; and.
2026-01-12
Sekisui Chemical Co., Ltd. expected to report Fiscal Year 2026 results on April 28, 2026. This event was calculated by S&P Global (Created on April 16, 2026).
2026-01-06
From October 30, 2025 to December 31, 2025, the company has repurchased 6,242,000 shares, representing 1.51% for ¥15,977.02 million. With this, the company has completed the repurchase of 6,242,000 shares, representing 1.51% for ¥15,977.02 million under the buyback announced on October 30, 2025.
2025-12-19
Sekisui Chemical Co., Ltd. announced that they will report Q3, 2026 results on Jan 29, 2026
2025-11-01
Sekisui Chemical Co., Ltd. expected to report Q3 2026 results on January 30, 2026. This event was calculated by S&P Global (Created on January 12, 2026).
2025-10-31
Sekisui Chemical Co., Ltd., ¥ 40.0, Cash Dividend, Mar-30-2026
2025-10-30
The Board of Directors of Sekisui Chemical Co., Ltd. has authorized a buyback plan on October 30, 2025.
2025-10-30
Sekisui Chemical Co., Ltd. (TSE:4204) announces a share repurchase program. Under the program, the company will repurchase 10,000,000 shares, representing 2.41% of its share capital, for ¥30,000 million. The company will repurchase its shares in order to improve capital efficiency, and to allow flexible capital policies corresponding to changes in the business environment. The program will run until March 31, 2026. As of September 30, 2025, the company had 415,093,471 shares outstanding (excluding treasury shares) and 25,413,814 shares in treasury.
2025-10-30
Sekisui Chemical Co., Ltd. revised consolidated earnings guidance for the fiscal Year ending March 31, 2026. for the year, the company now expects net sales of JPY 1,323,200 million, operating profit at JPY 110,000 million and profit attributable to owners of the parent at JPY 72,000 million, with earnings per share expected to be JPY 174.04 per share compared to previous guidance of net sales of JPY 1,364,500 million, operating profit at JPY 115,000 million and profit attributable to owners of the parent at JPY 82,000 million, with earnings per share expected to be JPY 196.39 per share.
2025-10-30
Sekisui Chemical Co., Ltd. announced the dividend of JPY 40.00 per share for the second quarter of fiscal year ending March 31, 2026, payable on December 1, 2025 against JPY 37.00 per share a year ago.
2025-10-30
Sekisui Chemical Co., Ltd., Board Meeting, Oct 30, 2025. Agenda: To consider the Notice Regarding Purchase of Treasury Shares and Cancellation of Treasury Shares.
2025-10-20
Sekisui Chemical Co., Ltd., Q2 2026 Earnings Call, Oct 30, 2025
2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 1,337,104 | 1,309,281 | 1,302,319 | 1,298,497 | 1,304,073 | 1,297,754 | 1,287,949 | 1,274,298 | 1,269,973 | 1,256,538 |
Pretax Income Excl.Unusual Items | 125,762 | 117,873 | 107,517 | 113,692 | 106,535 | 110,956 | 119,203 | 102,950 | 110,285 | 106,345 |
Total Assets | 1,461,706 | 1,427,933 | 1,403,667 | 1,374,803 | 1,290,432 | 1,330,786 | 1,332,748 | 1,307,044 | 1,297,201 | 1,323,243 |
Total Liabilities | 579,770 | 546,809 | 548,855 | 520,948 | 465,795 | 495,423 | 487,090 | 488,120 | 468,763 | 502,319 |
Cash & Cash Equivalents | 100,905 | 97,192 | 107,354 | 147,518 | 86,845 | 120,895 | 107,354 | 142,539 | 93,542 | 138,572 |
Total Common Equity | 851,269 | 851,189 | 824,279 | 825,248 | 795,765 | 807,345 | 816,175 | 790,242 | 798,770 | 792,329 |
Book Value Per Share (BVPS) | 2,108.14 | 2,108.44 | 2,022.95 | 1,994.76 | 1,923.88 | 1,930.81 | 1,954.7 | 1,892.59 | 1,913.38 | 1,880.29 |
Net Change in Cash | 8,009 | -28,452 | -1,576 | 11,410 | -6,696 | -5,472 | 7,276 | 11,000 | 9,142 | 41,159 |
Capital Expenditure | -105,012 | -100,781 | -90,048 | -59,145 | -60,927 | -58,104 | -51,694 | -48,100 | -45,926 | -46,070 |
On July 31, 2026, Sekisui Chemical shared its financial results for the second quarter of 2026, having revenues of 332.97B yen and net income of 12.79B yen, indicating a growth of 9.1% in revenue, accompanied by a positive change of approximately 0.3% in EPS relative to the same quarter last year.
In addition, the EBITDA margin improved from 11.58% in the corresponding quarter last year to 12.05%. Negatively, there is another notable figure. The quarterly free cash flow was -25.07B yen, which is a decrease of -18.99B yen over the same time last year. and it trades at 13.8x times current year's earnings, which is higher than the sector average (P/E 10.8x).